The buzz about anabolic androgenic steroids: Electrophysiological effects in excitable tissues

Neuroendocrinology

Volumn 96, Issue 2, 2012, Pages 141-151

  Oberlander, Joseph G ^a   Penatti, Carlos A A ^b   Porter, Donna M ^a   Henderson, Leslie P ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSIDADE NOVE DE JULHO   (Brazil)

Author keywords

Allosteric modulator; Anabolic steroid; Androgen receptor; Aromatase; Forebrain; GABAA receptor; Potassium channel

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANABOLIC AGENT; ANDROGEN; BENZODIAZEPINE DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; FLUTAMIDE; MEMBRANE PROTEIN; METANDIENONE; NANDROLONE DECANOATE; TESTOSTERONE CIPIONATE;

ADRENERGIC TRANSMISSION; ALLOSTERISM; ARTICLE; BINDING SITE; CENTRAL NERVOUS SYSTEM; DEPRESSION; ELECTROPHYSIOLOGY; GERM LINE; HYPOMANIA; IRRITABILITY; MANIA; MOOD DISORDER; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; SEXUAL BEHAVIOR; SOCIAL ISOLATION; SOMATIZATION; TESTICULAR FEMINIZATION;

ANABOLIC AGENTS; ANIMALS; BRAIN; HUMANS; ION CHANNELS; NEURONS; RECEPTORS, GABA-A; STEROIDS; SYNAPTIC TRANSMISSION; TESTOSTERONE CONGENERS;

EID: 84866539356     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000339123     Document Type: Article

References (129)

1. Basaria S, Wahlstrom JT, Dobs AS: Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001; 86:5108-5117.
2. Shahidi NT: A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther 2001; 23:1355-1390.
3. Woerdeman J, de Ronde W: Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting. Expert Opin Investig Drugs 2011; 20:87-97.
4. Kochakian C, Yesalis C: Anabolic-androgenic steroids: a historical perspective and definition; in Yesalis CE (ed): Anabolic Steroids in Sport and Exercise. Champaign, Human Kinetics, 2000, pp 4-33.
5. Llewellyn L: Anabolics, ed 6, revised. Jupiter, Body of Science, 2007.
6. Trenton AJ, Currier GW: Behavioural manifestations of anabolic steroid use. CNS Drugs 2005; 19:571-595.
7. Kanayama G, Hudson JI, Pope HG Jr: Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend 2008; 98:1-12.
8. Wu FC: Endocrine aspects of anabolic steroids. 1997;43:1289-1292.
9. Daly RC, Su TP, Schmidt PJ, Pickar D, Murphy DL, Rubinow DR: Cerebrospinal fluid and behavioral changes after methyltestos-terone administration: preliminary findings. Arch Gen Psychiatry 2001; 58:172-177.
10. Perry PJ, Kutscher EC, Lund BC, Yates WR, Holman TL, Demers L: Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. J Forensic Sci 2003; 48:646-651.
11. Matsumoto AM, Bremner WJ: Serum testosterone assays-accuracy matters. J Clin Endocrinol Metab 2004; 89:520-524.
12. Franke WW, Berendonk B: Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997; 43:1262-1279.
13. Gallaway S: The Steroid Bible, ed 3, revised. Honolulu, Belle International, 1997.
14. Singer N, Schmidt MS: Supplements for athletes draw alert from FDA. The New York Times, July 29, 2009, p B1.
15. Winters SJ: Androgens: endocrine physiology and pharmacology. NIDA Res Monogr 1990; 102:113-130.
16. Martini L, Melcangi RC, Maggi R: Androgen and progesterone metabolism in the central and peripheral nervous system. J Steroid Bio-chem Mol Biol 1993; 47:195-205.
17. Ryan KJ: Biological aromatization of steroids. J Biol Chem 1959; 234:268-272.
18. 3H]17-a-methyltestosterone in human subjects. J Endocrinol 1967; 37:37-55.
19. Papaconstantinou AD, Umbreit TH, Goer-ing PL, Brown KM: Effects of 17a-methyltes-tosterone on uterine morphology and heat shock protein expression are mediated through estrogen and androgen receptors. J Steroid Biochem Mol Biol 2002; 82:305-314.
20. de Gooyer ME, Oppers-Tiemissen HM, Ley-sen D, Verheul HA, Kloosterboer HJ: Tibo-lone is not converted by human aromatase to 7a-methyl-17a- ethynylestradiol (7a-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. Steroids 2003; 68:235-243.
21. Saartok T, Dahlberg E, Gustafsson JA: Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology 1984; 114:2100-2106.
22. Roselli CE: The effect of anabolic-androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area. Brain Res 1998; 792:271-276.
23. Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georga-kopoulos C: Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure. Steroids 2009; 74:172-197.
24. Attardi BJ, Page ST, Hild SA, Coss CC, Matsumoto AM: Mechanism of action of bolan-diol (19-nortestosterone-3ß, 17ß-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities. J Steroid Biochem Mol Biol 2010; 118:151-161.
25. Whitney AC, Clark AS: Effects of acute stanozolol treatment on puberty in female rats. Biol Reprod 2001; 64:1460-1465.
26. Pinna G, Costa E, Guidotti A: Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc Natl Acad Sci USA 2005; 102:2135-2140.
27. Penatti CA, Porter DM, Henderson LP: Chronic exposure to anabolic androgenic steroids alters neuronal function in the mammalian forebrain via androgen receptor-and estrogen receptor-mediated mechanisms. J Neurosci 2009; 29:12484-12496.
28. Kurling-Kailanto S, Kankaanpää A, Hauta-niemi J, Seppälä T: Blockade of androgen or estrogen receptors reduces nandrolone's ability to modulate acute reward-related neurochemical effects of amphetamine in rat brain. Pharmacol Biochem Behav 2010; 95:422-427.
29. Attardi BJ, Hild SA, Reel JR: Dimethandro-lone undecanoate: a new potent orally active androgen with progestational activity. Endocrinology 2006; 147:3016-3026.
30. Luzárdo OP, Machín RP, Díaz-Chico BN, Fernandez L: Photoaffinity labeling identification of a specific binding protein for the anabolic steroids stanozolol and danazol: an oligomeric protein regulated by age, pituitary hormones, and ethinyl estradiol. Endocrinology 2000; 141:3377-3387.
31. Mor G, Eliza M, Song J, Wiita B, Chen S, Naf-tolin F: 17a-methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture. J Steroid Biochem Mol Biol 2001; 79:239-246.
32. 450 aromatase, gonadotropin ß-subunits and FTZ-F1 in the orange-spotted grouper (Epinephelus coioides) during 17a-methyl-testosterone-induced precocious sex change. Mol Reprod Dev 2007; 74:665-673.
33. Penatti CAA, Henderson LP: Androgen actions on receptors and channels: regulation of electrical excitability and synaptic transmission; in Pfaff DW, Etgen A, Fahrbach S, Rubin R (eds): Hormones, Brain and Behavior. Amsterdam, Elsevier, 2009, pp 1245-1274.
34. Handelsman DJ: Commentary: androgens and "anabolic steroids": the one-headed janus. Endocrinology 2011; 152:1752-1754.
35. A receptors: from molecular mechanisms to CNS roles in reproduction, dysfunction and drug abuse; in Maue R (ed): Advances in Molecular and Cell Biology. 2004, pp 217-249.
36. A receptor mediated-behaviors; in Smith S (ed): Neurosteroid Effects in the Central Nervous System: The Role of the GABA A Receptor. Boca Raton, CRC Press LLC, 2004, pp 119-141.
37. Henderson LP: Steroid modulation of GABA A receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology 2007; 52:1439-1453.
38. A receptor-gated chloride ion transport. Life Sci 1996; 58:573-583.
39. A receptors in the rat. Horm Behav 1993; 27:568-583.
40. A receptor interactions: a focus on stress. Front Neurosci 2011; 5:131.
41. A receptor. Neurosci Lett 1995; 189:35-38.
42. 35 S] TBPS binding. J Pharmacol Exp Ther 1996; 279:186-193.
43. 372L GABAA receptors. Neuropharmacology 2002; 43:619-633.
44. A receptors by anabolic androgenic steroids. Neuropharmacology 2005; 49:300-316.
45. A receptors. J Physiol 2006; 573:571-593.
46. Belelli D, Herd MB, Mitchell EA, Peden DR, Vardy AW, Gentet L, Lambert JJ: Neuroac-tive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 2006; 138:821-829.
47. Jones MV, Westbrook GL: The impact of receptor desensitization on fast synaptic transmission. Trends Neurosci 1996; 19:96-101.
48. A Receptor. Boca Raton, CRC Press LLC, 2004, pp 63-75.
49. A receptors. Psychoneuroendocrinol-ogy 2009; 34(suppl 1):S67-S73.
50. Jones BL, Henderson LP: Trafficking and potential assembly patterns of e-containing GABA A receptors. J Neurochem 2007; 103:1258-1271.
51. A receptor function. Trends Pharmacol Sci 1995; 16:295-303.
52. Clark AS, Henderson LP: Behavioral and physiological responses to anabolic-andro-genic steroids. Neurosci Biobehav Rev 2003; 27:413-436.
53. Clark AS, Costine BA, Jones BL, Kelton-Rehkopf MC, Meerts SH, Nutbrown-Greene LL, Penatti CA, Porter DM, Yang P, Henderson LP: Sex-and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions. Brain Res 2006; 1126:122-138.
54. Ojeda SR, Dubay C, Lomniczi A, Kaidar G, Matagne V, Sandau US, Dissen GA: Gene networks and the neuroendocrine regulation of puberty. Mol Cell Endocrinol 2010; 324:3-11.
55. Semaan SJ, Kauffman AS: Sexual differentiation and development of forebrain reproductive circuits. Curr Opin Neurobiol 2010; 20:424-431.
56. A receptor activation on gonadotrophin-releasing hormone neurones: towards an emerging consensus. J Neuroendocrinol 2011; 23:557-569.
57. Irving LM, Wall M, Neumark-Sztainer D, Story M: Steroid use among adolescents: findings from Project EAT. J Adolesc Hea lth 2002; 30:243-252.
58. Joh nston L, O'Malley P, Bachman J, Schulenberg J: Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2008. Bethesda, National Institute on Drug Abuse, 2009, p 73.
59. Sato SM, Schulz KM, Sisk CL, Wood RI: Adolescents and androgens, receptors and re-wa rds. Horm Behav 2008; 53:647-658.
60. Schulz KM, Zehr JL, Salas-Ramirez KY, Sisk CL: Testosterone programs adult social behavior before and during, but not after, adolescence. Endocrinology 2009; 150:3690-3698.
61. A receptor-mediated synaptic transmission disrupts the firing of gonadotropin-releasing hormone neurons in male mice under conditions that mimic steroid abuse. J Neurosci 2010; 30:6497-6506.
62. Penatti CA, Oberlander JG, Davis MC, Porter DM, Henderson LP: Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse. Neuro-pharmacology 2011; 61:653-664.
63. Simerly RB: Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain. A nnu Rev Neurosci 2002; 25:507-536.
64. Simerly RB, Chang C, Muramatsu M, Swan-son LW: Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 1990; 294:76-95.
65. 2 receptors reduces androgen receptor expression in the rat anteroventral periventricular nucleus and sexually dimorphic preoptic a re a. Eur J Neu rosci 2008; 27:2473-2480.
66. Scott CJ, Tilbrook AJ, Rawson JA, Clarke IJ: Gonadal steroid receptors in the regulation of GnRH secretion in farm animals. Anim Reprod Sci 2000; 60-61:313-326.
67. Grattan DR, Jasoni CL, Liu X, Anderson GM, Herbison AE: Prolactin regulation of gonadotropin-releasing hormone neurons to suppress luteinizing hormone secretion in mice. Endocr i nolog y 2007; 148:4344-4351.
68. Herbison AE: Estrogen positive feedback to gonadotropin-releasing hormone (GnRH) neurons in the rodent: the case for the rostral periventricular area of the third ventricle (R P3V). Brain Res Rev 2008; 57:277-287.
69. Penatti CA, Costine BA, Porter DM, Henderson LP: Effects of chronic exposure to an anabolic androgenic steroid cocktail on a5-re-ceptor-mediated GABAergic transmission and neural signaling in the forebrain of female mice. Neuroscience 2009; 161:526-537.
70. Herbison AE: Estrogen regulation of GABA transmission in rat preoptic area. Brain Res Bull 1997; 44:321-326.
71. Midgley SJ, Heather N, Davies JB: Levels of aggression among a group of anabolic-an-drogenic steroid users. Med Sci Law 2001; 41:309-314.
72. Gruber AJ, Pope HG Jr: Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom 2000; 69:19-26.
73. Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS: Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. Eur Psychiatry 2006; 21:551-562.
74. Malone DA Jr, Dimeff RJ, Lombardo JA, Sample RH: Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sport Med 1995; 5:25-31.
75. Oberlander JG, Henderson LP: Corticotropin releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse. Neuropsycho-pharmacology 2012; 37:1483-1499.
76. Davis M, Walker DL, Miles L, Grillon C: Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010; 35:105-135.
77. Costine BA, Oberlander JG, Davis MC, Penatti CA, Porter DM, Leaton RN, Henderson LP: Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse. Psychoneuroendocrinology 2010; 35:1473-1485.
78. Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M, Cottone P, Madamba SG, Stouffer DG, Zorrilla EP, Koob GF, Sig-gins GR, Parsons LH: Corticotropin releasing factor-induced amygdala gamma-ami-nobutyric acid release plays a key role in alcohol dependence. Biol Psychiatry 2010; 67:831-839.
79. Roberto M, Madamba SG, Moore SD, Tallent MK, Siggins GR: Ethanol increases GABAergic transmission at both pre-and postsynaptic sites in rat central amygdala neurons. Proc Natl Acad Sci USA 2003; 100:2053-2058.
80. Roberto M, Madamba SG, Stouffer DG, Parsons LH, Siggins GR: Increased GABA release in the central amygdala of ethanol-de-pendent rats. J Neurosci 2004; 24:10159-10166.
81. Cruz MT, Herman MA, Kallupi M, Roberto M: Nociceptin/orphanin FQ blockade of corticotropin-releasing factor-induced gam-ma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure. Biol Psychiatry 2012; 71:666-676.
82. Conrad KL, Winder DG: Altered anxietylike behavior and long-term potentiation in the bed nucleus of the stria terminalis in adult mice exposed to chronic social isolation, unpredictable stress, and ethanol beginning in adolescence. Alcohol 2011; 45:585-593.
83. Pibiri F, Nelson M, Guidotti A, Costa E, Pinna G: Decreased corticolimbic allopreg-nanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder. Proc Natl Acad Sci USA 2008; 105:5567-5572.
84. Pinna G, Agis-Balboa RC, Zhubi A, Matsu-moto K, Grayson DR, Costa E, Guidotti A: Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation. Proc Natl Acad Sci USA 2006; 103:4275-4280.
85. Agis-Balboa RC, Pibiri F, Nelson M, Pinna G: Enhanced fear responses in mice treated with anabolic androgenic steroids. Neuroreport 2009; 20:617-621.
86. Lin HC, Mao SC, Gean PW: Block of 7-ami-nobutyric acid-A receptor insertion in the amygdala impairs extinction of conditioned fear. Biol Psychiatry 2009; 66:665-673.
87. Oberlander JG, Henderson LP: The sturm und drang of anabolic steroid use: angst, anxiety, and aggression. Trends Neurosci 2012, E-pub ahead of print.
88. A receptor subunit mRNAs in the mouse forebrain. Neuropharmacology 2002; 43:634-645.
89. Pibiri F, Nelson M, Carboni G, Pinna G: Neurosteroids regulate mouse aggression induced by anabolic androgenic steroids. Neuroreport 2006; 17:1537-1541.
90. Robinson S, Penatti CA, Clark AS: The role of the androgen receptor in anabolic androgenic steroid-induced aggressive behavior in C57BL/6J and Tfm mice. Horm Behav 2012; 61:67-75.
91. A receptors. Proc Natl Acad Sci USA 2002; 99:8980-8985.
92. Yee BK, Keist R, von Boehmer L, Studer R, Benke D, Hagenbuch N, Dong Y, Malenka RC, Fritschy JM, Bluethmann H, Feldon J, Möhler H, Rudolph U: A schizophrenia-related sensorimotor deficit links a3-contain-ing GABA A receptors to a dopamine hyper-function. Proc Natl Acad Sci USA 2005; 102:17154-17159.
93. A-asso-ciated genes in the amygdala after the acquisition and extinction of Pavlovian fear. Eur J Neurosci 2007; 26:3631-3644.
94. Tasan RO, Bukovac A, Peterschmitt YN, Sartori SB, Landgraf R, Singewald N, Sperk G: Altered GABA transmission in a mouse model of increased trait anxiety. Neuroscience 2011; 183:71-80.
95. Matrisciano F, Modafferi AM, Togna GI, Barone Y, Pinna G, Nicoletti F, Scaccianoce S: Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior. Neuropharmacolog y 2010; 58:1078-1084.
96. Rossbach UL, Steensland P, Nyberg F, Le Grevès P: Nandrolone-induced hippocam-pal phosphorylation of NMDA receptor subunits and ERKs. Biochem Biophys Res Commun 2007; 357:1028-1033.
97. A synapticresponsesby brain-derived neurotrophic factor (BDNF) in rat hippocampus. J Neurosci 1997; 17:2959-2966.
98. A receptors via different tyrosine receptor kinase B-mediated phosphorylation pathways. Neuroscience 2011; 176:72-85.
99. Lu H, Cheng PL, Lim BK, Khoshnevisrad N, Poo MM: Elevated BDNF after cocaine withdrawal facilitates LTP in medial pre-frontal cortex by suppressing GABA inhibition. Neuron 2010;67:821-833.
100. Chand D, Lovejoy DA: Stress and reproduction: controversies and challenges. Gen Comp Endocrinol 2011;171:253-257.
101. Veldhuis JD, Keenan DM, Pincus SM: Regulation of complex pulsatile and rhythmic neuroendocrine systems: the male gonadal axis as a prototype. Prog Brain Res 2010; 181:79-110.
102. Li XF, Knox AMI, O'Byrne KT: Corticotro-pin-releasing factor and stress-induced inhibition of the gonadotropin-releasing hormone pulse generator in the female. Brain Res 2010;1364:153-163.
103. Cunningham RL, Lumia AR, McGinnis MY: Androgen receptors, sex behavior, and aggression. Neuroendocrinology 2012;96:131-140.
104. MacLusky NJ, Naftolin F, Leranth C: Im-munocytochemical evidence for direct syn-aptic connections between corticotrophin-releasing factor (CRF) and gonadotrophin-releasing hormone (GnRH)-containing neurons in the preoptic area of the rat. Brain Res 1988;439:391-395.
105. Keegan CE, Herman JP, Karolyi IJ, O'Shea KS, Camper SA, Seasholtz AF: Differential expression of corticotropin-releasing hormone in developing mouse embryos and adult brain. Endocrinology 1994;134:2547-2555.
106. Lin YS, Li XF, Shao B, Hu MH, Goundry AL, Jeyaram A, Lightman SL, O'Byrne KT: The role of GABAergic signalling in stress-induced suppression of GnRH pulse generator frequency in female rats. J Neuroen-docrinol 2012;24:477-488.
107. Jasoni CL, Todman MG, Han SK, Herbison AE: Expression of mRNAs encoding receptors that mediate stress signals in gonado-tropin-releasing hormone neurons of the mouse. Neuroendocrinology 2005;82:320-328.
108. Bass AH, Volman SF: From behavior to membranes: testosterone-induced changes in action potential duration in electric organs. Proc Natl Acad Sci USA 1987;84:9295-9298.
109. Bass AH, Zakon HH: Sonic and electric fish: at the crossroads of neuroethology and behavioral neuroendocrinology. Horm Be-hav 2005;48:360-372.
110. Ferrari MB, McAnelly ML, Zakon HH: Individual variation in and androgen-modulation of the sodium current in electric organ. J Neurosci 1995;15:4023-4032.
111. + current in the electric organ of a weakly electric fish. Dev Neurobiol 2007;67:1589-1597.
112. Medei E, Marocolo M, Rodrigues de Car-valho Rodrigues, Arantes PC, Takiya CM, Silva J, Rondinelli E, Goldenberg RC, de Carvalho AC, Nascimento JH: Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: cellular, ionic and molecular mechanism. J Mol Cell Cardiol 2010;49:165-175.
113. Pereira-Junior PP, Chaves EA, Costa ESRH, Masuda MO, De Carvalho AC, Nascimento JH: Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur J Appl Physiol 2006;96:487-494.
114. Bouhlel A, Joumaa WH, Léoty C: Nandro-lone decanoate reduces changes induced by hindlimb suspension in voltage-dependent tension of rat soleus muscle. Jpn J Physiol 2003;53:77-87.
115. 2+ ATPase function in skinned rat slow-and fast-twitch fibres. Pflugers Arch 2003;446:728-734.
116. Johansson-Steensland P, Nyberg F, Chahl L: The anabolic androgenic steroid, nan-drolone decanoate, increases the density of Fos-like immunoreactive neurons in limbic regions of guinea-pig brain. Eur J Neurosci 2002;15:539-544.
117. Tamaki T, Shiraishi T, Takeda H, Matsu-miya T, Roy RR, Edgerton VR: Nandrolone decanoate enhances hypothalamic biogen-ic amines in rats. Med Sci Sports Exerc 2003;35:32-38.
118. Carrillo M, Ricci LA, Melloni RH Jr: Adolescent anabolic androgenic steroids reorganize the glutamatergic neural circuitry in the hypothalamus. Brain Res 2009; 1249:118-127.
119. Le Grevès P, Huang W, Johansson P, Thorn-wall M, Z hou Q, Nyberg F: Effects of an an-abolic-androgenic steroid on the regulation of the NMDA receptor NR1, NR2A and NR2B subunit mRNAs in brain regions of the male rat. Neurosci Lett 1997; 226:61-64.
120. 2 receptors in the male rat brain. Neuroscience 2003; 119:113-120.
121. Grimes JM, Melloni RH Jr: Serotonin-1B receptor activity and expression modulate the aggression-stimulating effects of adolescent anabolic steroid exposure in hamsters. Behav Neurosci 2005; 119:1184-1194.
122. Grimes JM, Melloni RH Jr: Prolonged alterations in the serotonin neural system following the cessation of adolescent anabol-ic-androgenic steroid exposure in hamsters (Mesocricetus auratus). Behav Neurosci 2006; 120:1242-1251.
123. Ambar G, Chiavegatto S: Anabolic-andro-genic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the pre-frontal cortex and amygdala of male mice. Genes Brain Behav 2009; 8:161-173.
124. 2A receptors in aggressive male hamsters. Behav Brain Res 2009; 199:257-262.
125. Kindlundh AM, Lindblom J, Bergström L, Wikberg JE, Nyberg F: The anabolic-an-drogenic steroid nandrolone decanoate affects the density of dopamine receptors in the ma le rat brain. Eur J Neurosci 2001; 13:291-296.
126. Ricci LA, Schwartzer JJ, Melloni RH Jr: Alterations in the anterior hypothalamic do-pamine system in aggressive adolescent AAS-treated hamsters. Horm Behav 2009; 55:348-355.
127. Schwartzer JJ, Melloni RH Jr: Anterior hy-pothalamic dopamine D2 receptors modulate adolescent anabolic/androgenic steroid-induced offensive aggression in the Syrian hamster. Behav Pharmacol 2010; 21:314-322.
128. Schwartzer JJ, Melloni RH Jr: Dopamine activity in the lateral anterior hypothalamus modulates AAS-induced aggression through D2 but not D5 receptor s. Behav Neurosci 2010; 124:645-655.
129. Rossbach UL, Le Grevès M, Nyberg F, Zhou Q, Le Grevès P: Acute 19-nortestosterone transiently suppresses hippocampal MAPK pathway and the phosphorylation of the NM DA receptor. Mol Cell Endocrinol 2010; 314:143-149.